Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ANZCTR |
Last refreshed on:
|
13 January 2020 |
Main ID: |
ACTRN12615000714583 |
Date of registration:
|
10/07/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Coping Skills Training for Living With Chronic Low Back Pain
|
Scientific title:
|
Mechanisms of Mindfulness Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Low Back Pain |
Date of first enrolment:
|
20/01/2016 |
Target sample size:
|
63 |
Recruitment status: |
Completed |
URL:
|
https://anzctr.org.au/ACTRN12615000714583.aspx |
Study type:
|
Interventional |
Study design:
|
Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;
|
Phase:
|
Not Applicable
|
|
Countries of recruitment
|
Australia
| | | | | | | |
Contacts
|
Name:
|
Dr Melissa Day
|
Address:
|
330 McElwain Building
School of Psychology
The University of Queensland
Brisbane, QLD 4072
Australia |
Telephone:
|
+61 7 3365 6421 |
Email:
|
m.day@uq.edu.au |
Affiliation:
|
|
|
Name:
|
Dr Melissa Day
|
Address:
|
330 McElwain Building
School of Psychology
The University of Queensland
Brisbane, QLD 4072
Australia |
Telephone:
|
+61 7 3365 6421 |
Email:
|
m.day@uq.edu.au |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: (1) at least 18 years of age; (2) chronic pain of the low back (at least 3 months) that is the primary source of reported pain; (3) average pain intensity of at least 4 on a 10-point scale; (4) if currently taking analgesic or psychotropic medications, they must have been stabilised for at least 4 weeks prior to this study; (5) be able to read, speak and understand English; and (6) be able to attend a weekly 2-hour therapy session for 8 concurrent weeks.
Exclusion criteria: (1) cognitive impairment, uncontrolled psychotic symptoms or current elevated suicidal ideation as this may interfere with group-delivered therapy (as evidenced by the 6-item screener); (2) chronic pain due to malignancy; (3) history of a medical condition that could produce an abnormal EEG and interfere with the tests of the effects of treatment on EEG (e.g., epilepsy, history of traumatic brain injury); and (4) currently receiving other psychosocial pain treatment.
Age minimum:
18 Years
Age maximum:
No limit
Gender:
Both males and females
|
Health Condition(s) or Problem(s) studied
|
Low back pain; Low back pain
|
Alternative and Complementary Medicine - Other alternative and complementary medicine
|
Musculoskeletal - Other muscular and skeletal disorders
|
Intervention(s)
|
Eight, group delivered 2 hours sessions (1 per week) of either:
(1) mindfulness meditation - various mindfulness meditation techniques are taught as means to reduce stress and improve coping and management of pain.
or
(2) cognitive therapy - exercises such as cognitive restructuring are taught to change unhelpful ways of thinking and responding to pain to improve pain management.
or
(3) mindfulness-based cognitive therapy - both mindfulness meditation and cognitive coping techniques are taught to improve adaptive pain coping and management.
Each participant receives all 8 sessions for one of the above three interventions only. Between session practice is encouraged and recorded via participant self-report. All interventions are group delivered by a clinical psychologist.
|
Primary Outcome(s)
|
Pain Interference, assessed via the PROMIS pain interference scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Secondary Outcome(s)
|
Pain catastrophizing, assessed via the Pain Catastrophizing Scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Pain intensity, assessed via a numerical rating scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Psychological functioning, assessed via the PROMIS scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Pain acceptance, assessed via the CPAQ[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Physical functioning, assessed via the PROMIS scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Emotional functioning, assessed via the PROMIS scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Mindfulness, assessed via the FFMQ[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
|
Secondary ID(s)
|
Nil Known
|
Source(s) of Monetary Support
|
National Health and Medical Research Council
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Behavioural & Social Sciences Ethical Review Committee
|
Status: Approved
Approval date:
Contact:
Metro South Hospital and Health Service Human Research Ethics Committee
|
Results
|
Results available:
|
Yes |
Date Posted:
|
17/05/2019 |
Date Completed:
|
30/06/2018 |
URL:
|
|
|
|